Aprea Therapeutics

APRE

0.58425.41% ( -0.0334 )

Closed: Oct 16, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.63, within the reasonable range, cheaper than 47.51% of the time in the past 1 years, and the industry ranks 164/604, the industry Median -1.93.

-0.632xP/E

Stock price$0.62Earnings per share$-0.98

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GILDUSGilead Sciences	-60.23x	150.48%	$195.13B
MRNAUSModerna	-29.96x	15.45%	$94.42B
CSLLYUSCSL Limited	-24.21x	--	$62.45B
NTRAUSNatera	-303.35x	6.85%	$58.35B
RVMDUSRevolution Medicines	-22.94x	61.92%	$40.57B
ROIVUSRoivant Sciences	-92.35x	146.49%	$24.59B
BNTXUSBioNTech SE	-11.59x	19.07%	$22.66B
INSMUSInsmed	-24.75x	74.51%	$21.67B
BBIOUSBridgebio Pharma	-18.97x	28.67%	$13.12B
SMMTUSSummit Therapeutics	-14.32x	20.67%	$12.26B
MDGLUSMadrigal Pharma	-32.68x	51.32%	$10.62B
IBRXUSImmunityBio	-10.68x	153.51%	$10.60B
PCVXUSVaxcyte	-9.65x	48.18%	$10.27B
TWSTUSTwist Bioscience	-69.58x	28.71%	$9.51B
KYMRUSKymera Therapeutics	-30.01x	5.24%	$8.99B
CYTKUSCytokinetics	-9.94x	6.73%	$8.89B
ARWRUSArrowHead Pharma	-25.83x	35,923.70%	$8.26B
ABVXUSAbivax SA	-17.32x	22.49%	$8.05B
IONSUSIonis Pharma	-12.97x	50.43%	$7.33B
SYREUSSpyre Therapeutics	-47.02x	45.67%	$7.06B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.